Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity

Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.

6,726 public trials 634 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity trial results

Active, Not Recruiting

Seal, Stopping Eczema and Allergy Study

NCT03742414

Conditions
Atopic Dermatitis, Atopic Dermatitis Eczema, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
Locations
  • Sean N. Parker Center for Allergy & Asthma Research at Stanford University Palo Alto, California, United States
  • Division of Pediatric Allergy and Clinical Immunology, National Jewish Health Denver, Colorado, United States
  • University of Chicago Chicago, Illinois, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details
Active, Not Recruiting

Study in Paediatric Patients With Atopic Dermatitis Treated With Dupilumab in Spain

NCT06415175

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Investigational Site Number : 7240004 Santiago de Compostela, A Coruña [La Coruña], Spain
  • Investigational Site Number : 7240006 Esplugues de Llobregat, Barcelona [Barcelona], Spain
  • Investigational Site Number : 7240005 Oviedo, Principality of Asturias, Spain
  • Investigational Site Number : 7240008 Seville, Sevilla, Spain
View all 15 locations
View Trial Details
Active, Not Recruiting

Investigating Dupilumab's Effect in Asthma by Genotype

NCT03694158

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Boston Children's Hospital Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Montefiore Einstein Clinical Research Center The Bronx, New York, United States
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis

NCT06718101

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Peak Dermatology Aesthetics and Wellness Fountain Hills /ID# 272550 Fountain Hills, Arizona, United States
  • Dermatology Research Associates - Los Angeles /ID# 272945 Los Angeles, California, United States
  • Integrative Skin Science and Research /ID# 274243 Sacramento, California, United States
  • Clinical Trials Research Institute /ID# 274234 Thousand Oaks, California, United States
View all 30 locations
View Trial Details
Active, Not Recruiting

Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Children From 2 to Less Than 12 Years of Age in Japan With Moderate to Severe Atopic Dermatitis

NCT06701331

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Central Clinic - Nagoya /ID# 269205 Nagoya, Aichi-ken, Japan
  • Fujita Health University Hospital /ID# 269201 Toyoake, Aichi-ken, Japan
  • Miyata Dermatology Clinic /ID# 269200 Matsudo-Shi, Chiba, Japan
  • Hoshikuma Dermatology ・ Allergy Clinic /ID# 270192 Fukuoka, Japan
View all 25 locations
View Trial Details
Active, Not Recruiting

A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Participants From Jasper-Sponsored Chronic Urticaria Trials

NCT06736262

Conditions
Chronic Disease, Chronic Urticaria, Disease Attributes, +13 more
Locations
  • Investigative Site 118 Birmingham, Alabama, United States
  • Investigative Site 108 Little Rock, Arkansas, United States
  • Investigative Site 105 San Diego, California, United States
  • Investigative Site 116 Tampa, Florida, United States
View all 19 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Immunogenicity of APG777 in Adults With Asthma

NCT06920901

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Investigational Site La Jolla, California, United States
  • Investigational Site Long Beach, California, United States
  • Investigational Site San Jose, California, United States
  • Investigational Site Torrance, California, United States
View Trial Details
Active, Not Recruiting

A Study to Investigate the Effect on Lung Function of BDA Formulated With a Next Generation Propellant Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma

NCT06502366

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Research Site Mobile, Alabama, United States
  • Research Site Sheffield, Alabama, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Little Rock, Arkansas, United States
View all 128 locations
View Trial Details

Related conditions